Genetic Causes
Heterozygous familial hypercholesterolemia (HeFH) is caused by a gene mutation passed down from one parent. This mutation usually affects the LDL receptor gene, which is responsible for clearing low-density lipoprotein (LDL) cholesterol from the blood. Because the receptors on the liver cells do not function correctly, cholesterol remains in the bloodstream and builds up over time. Since it is an autosomal dominant disorder, inheriting the gene from just one parent is enough to cause the condition.

Risk Factors
The primary risk factor for HeFH is a family history of the condition or premature heart disease. If a parent, sibling, or child has HeFH, there is a 50 percent chance of sharing the mutation. While lifestyle factors like a poor diet, lack of exercise, and smoking do not cause the genetic mutation, they can worsen the severity of the cholesterol buildup and increase the risk of heart attacks. High lipoprotein(a) levels are an additional genetic risk factor often found in these patients.

Prevention
Primary prevention of the genetic condition itself is not possible because it is inherited at conception. However, cascade screening—testing close relatives of a diagnosed patient—is the most effective way to identify carriers early. Secondary prevention is highly effective and focuses on preventing complications. Starting cholesterol-lowering treatment early in life prevents the cumulative damage to arteries that leads to heart disease.

Signs and Symptoms
HeFH is often a "silent" condition, meaning many people have no visible symptoms until they develop heart disease. However, physical signs can appear due to cholesterol deposits. These include xanthomas (fatty bumps on the knuckles, elbows, knees, or Achilles tendon) and xanthelasmas (yellowish patches on the eyelids). A corneal arcus, which is a white or gray ring around the colored part of the eye, may also be visible, particularly in younger patients. Without treatment, the first symptom may be chest pain (angina) or a heart attack at a young age, typically in the 30s, 40s, or 50s.

Diagnostic Tests
Clinicians identify HeFH primarily through a lipid panel blood test. In adults, LDL cholesterol levels above 190 mg/dL, or above 160 mg/dL in children, typically trigger further investigation. A detailed review of family history is crucial; a pattern of high cholesterol or early heart attacks in first-degree relatives strongly suggests the diagnosis. Genetic testing can confirm the specific mutation (such as in the LDLR, APOB, or PCSK9 genes), though a clinical diagnosis can often be made without it based on lipid levels and family history.

Differential Diagnosis
Doctors must distinguish HeFH from polygenic hypercholesterolemia, where high cholesterol is caused by a combination of many minor genetic factors and lifestyle choices rather than a single major mutation. They also rule out secondary causes of high cholesterol, such as hypothyroidism, kidney disease, or liver disease.

Medications
Medication is almost always required for HeFH because diet alone cannot correct the genetic defect. High-intensity statins are the standard first-line treatment to lower LDL levels aggressively. If statins are not enough, doctors may add ezetimibe, which blocks cholesterol absorption in the gut. For patients who still do not reach their goals, PCSK9 inhibitors (injectable medications) or bempedoic acid may be prescribed. Bile acid sequestrants are an older class of drugs that are sometimes used as well.

Lifestyle and Self-Care
While medication addresses the genetic cause, lifestyle changes are essential to reduce overall cardiovascular risk. This includes eating a heart-healthy diet low in saturated and trans fats, engaging in regular aerobic exercise, and maintaining a healthy weight. avoiding tobacco is critical, as smoking drastically accelerates heart disease in people with high cholesterol.

Monitoring and Follow-Up
Management involves regular lipid panels to monitor cholesterol levels and adjust medication dosages. Patients often require care from a lipid specialist or cardiologist. Routine imaging, such as a coronary calcium scan or stress test, may be recommended to check for early signs of heart disease.

When to Seek Medical Care
Patients should see a doctor if they experience chest pain, shortness of breath, or palpitations, as these may be signs of blocked arteries. Immediate emergency care is needed for symptoms of a heart attack, such as crushing chest pain or pain radiating to the arm or jaw. Routine appointments are necessary to ensure LDL levels remain within the target range.

Severity and Complications
HeFH is a serious medical condition. It is considered less severe than the rare homozygous form (where two mutation copies are inherited), but it is still a major health risk. The severity depends largely on how high the LDL levels are and the presence of other risk factors like smoking or high blood pressure. The primary complication is coronary artery disease, which can lead to narrowing of the arteries, angina, heart attacks, and stroke much earlier than in the general population.

Prognosis and Life Expectancy
The prognosis for HeFH has improved dramatically with modern medicine. If diagnosed in childhood or young adulthood and treated effectively, individuals can have a normal life expectancy matching that of the general population. However, if left untreated, men have a 50 percent risk of having a fatal or non-fatal coronary event by age 50, and women have a 30 percent risk by age 60. The cumulative burden of high cholesterol over decades is what drives this risk, emphasizing the need for early intervention.

Impact on Daily Activities
Living with HeFH typically does not limit physical mobility or daily activities unless heart disease has already developed. The main impact on daily life involves the routine of taking medications and adhering to a strict diet. Some patients may feel anxiety or stress regarding their long-term health or the health of their children, given the hereditary nature of the disease. Joining patient support groups can provide emotional support and practical tips for navigating life with a chronic genetic condition.

Questions to Ask Your Healthcare Provider
Patients should be proactive in their care. Useful questions to ask include:

• What is my specific LDL cholesterol target number?
• Should my children or siblings be tested for this condition?
• Am I a candidate for genetic testing?
• What are the potential side effects of my cholesterol medication?
• How often should I have my heart health checked with imaging tests?
• Are there specific dietary changes that will help my medication work better?

Q: Is Heterozygous familial hypercholesterolemia the same as just having high cholesterol?
A: No. HeFH is a genetic disorder where cholesterol levels are extremely high from birth, whereas general high cholesterol often develops later in life due to diet and aging. The risk of heart disease is much higher in HeFH because the arteries are exposed to high cholesterol for a longer period.

Q: Can I lower my cholesterol to normal levels with diet and exercise alone?
A: It is very unlikely. While a healthy lifestyle helps, the genetic defect in the liver prevents it from clearing cholesterol effectively regardless of diet. Medication is almost always necessary to bring LDL levels down to a safe range.

Q: Is it safe to have children if I have HeFH?
A: Yes, but there is a 50 percent chance of passing the gene to each child. It is important to discuss family planning with your doctor, as some cholesterol medications must be stopped during pregnancy.

Q: Why do I need to take medication if I feel fine?
A: High cholesterol is a silent killer that damages arteries without causing pain until a blockage occurs. Taking medication prevents this invisible damage and protects you from future heart attacks or strokes.

Q: At what age should my children be screened?
A: Guidelines recommend that children of parents with HeFH be screened typically between the ages of 2 and 10 to catch the condition early.